top of page
Combating Drug Resistant Bacterial Infections
Our novel antibiotic is being developed for treatment of antibiotic resistant pathogens such as MRSA.
Advisors
Our advisors combine real-world expertise with decades of academic research experience. They provide consult in niche scientific challenges encountered during research and development, and offer insights into new projects Sano undertakes.
bottom of page